Probiotic supplements produce at best a small, inconsistent reduction in eczema severity according to a 2018 Cochrane review of 39 trials, and the evidence is stronger for preventing eczema in high-risk infants than for treating established eczema in adults. If you choose to try them, Lactobacillus rhamnosus GG or Lactobacillus reuteri at a minimum of 1 billion CFU daily have the best evidence, but they should be seen as a supporting element rather than a treatment.
The gut-skin axis
The gut microbiome, the community of microorganisms living in the intestine, plays a significant role in immune system development and regulation. Much of the immune system is located in the gut-associated lymphoid tissue (GALT), and the microbiome communicates with it constantly. A diverse, balanced microbiome supports balanced immune function; a depleted or dysbiotic microbiome is associated with immune dysregulation.
In eczema, gut microbiome differences are well-documented. Studies consistently show that infants and children with eczema have reduced microbial diversity compared to those without eczema, with specific differences in the proportions of Lactobacillus and Bifidobacterium species. The critical question is whether this is a cause or a consequence of the condition, and the evidence increasingly suggests it's both.
What the probiotic trials show
Multiple randomised controlled trials have tested whether probiotic supplementation improves eczema outcomes. The results are consistently modest and inconsistent across trials. A 2018 Cochrane systematic review of 39 trials involving 2,599 participants found that probiotics produced a small reduction in eczema severity but the clinical significance was uncertain and the evidence quality was low.
The most positive results are in prevention rather than treatment. Specifically, maternal probiotic supplementation during pregnancy and early infant supplementation in high-risk infants shows some evidence for reducing the incidence of eczema. Using probiotics to treat established eczema is less well-supported.
Strain specificity matters enormously. Different probiotic strains have different effects. Lactobacillus rhamnosus GG and Lactobacillus reuteri have better evidence than most others, but even these show inconsistent results across trials. Generic "probiotic" supplements containing whichever strains are cheapest to manufacture are unlikely to replicate the effects seen in trials.
Why the evidence is mixed
Probiotic research is difficult to conduct well. The microbiome is highly individual, and what constitutes a "good" microbiome varies by person. The strains available in commercial supplements are a tiny fraction of the hundreds of bacterial species in the gut. And the route of administration, oral supplementation, means most bacteria don't survive the journey to the colon where they'd have most effect.
The practical position
Probiotics with reasonable evidence, specifically L. rhamnosus GG or L. reuteri in doses of at least 1 billion CFU daily, are a reasonable addition to a comprehensive eczema management protocol. They're safe, relatively affordable, and may contribute to immune regulation even if the effect size is modest. They should be seen as a supporting element, not a treatment.
Prebiotic fibre, which feeds beneficial bacteria already present in the gut, may be at least as important as probiotic supplementation. A diet high in diverse plant foods, particularly legumes, vegetables, and whole grains, provides the substrate that a healthy microbiome needs to thrive.
Reviewed by the xmahub protocol team. Based on peer-reviewed dermatology literature.